Furthermore, we demonstrated that UBE2T suppressed the expression of Mule in HCC cells by facilitating degradation of Mule via ubiquitination, and this effect was dependent on its E2 enzymatic activity at the conserved cysteine residue C86. The gene discussed is UBE2T; the disease is hepatocellular carcinoma.